Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Other Non Operating Income (2024 - 2025)

Silence Therapeutics' Other Non Operating Income history spans 2 years, with the latest figure at -$2.8 million for Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 75.39% year-over-year to -$2.8 million; the TTM value through Sep 2025 reached $3.5 million, changed N/A, while the annual FY2024 figure was $646000.0, 64.17% down from the prior year.
  • Other Non Operating Income for Q3 2025 was -$2.8 million at Silence Therapeutics, up from -$6.6 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $11.9 million in Q4 2024 and bottomed at -$11.4 million in Q3 2024.